Alcon and RxSight are collaborating to develop adjustable presbyopia-correcting intraocular lenses to improve vision outcomes for patients [1, 2].
This partnership represents a shift toward post-operative flexibility in eye care. By allowing lenses to be adjusted after surgery, surgeons can more precisely fine-tune a patient's vision, potentially reducing the need for secondary corrective procedures.
The initiative was highlighted during the Vision Expo 2026 edition in Orlando, Florida [3]. This specific event marks the start of a new chapter for the exhibition, which serves as a hub for showcasing the future of eye-care technology [3]. Alcon, a global leader in the sector, used the platform to demonstrate its ongoing innovation journey and its commitment to advancing surgical outcomes [1, 2].
The collaboration focuses on presbyopia, the age-related loss of the eye's ability to focus on nearby objects. While traditional intraocular lenses are static once implanted, the new adjustable PCIOLs aim to provide a dynamic solution that can be modified to meet the specific needs of the patient after the initial operation [1, 2].
Broader trends in medical technology are also emerging in the U.S. market. LensCrafters announced the launch of its Vision & Eye Health Center in New York on June 30, 2026 [4]. This center integrates eye health services with med-tech capabilities, mirroring the industry-wide push toward comprehensive, technology-driven care [4].
Together, these developments signal a transition from standardized implants to personalized, adjustable medical devices. The integration of such technology into both surgical practices and retail health centers suggests a more holistic approach to vision correction in 2026 [1, 3, 4].
“The collaboration aims to bring post-operative adjustability to presbyopia-correcting lenses.”
The move toward adjustable intraocular lenses shifts the risk of surgical precision from the moment of implantation to the post-operative period. By partnering with RxSight, Alcon is attempting to standardize a 'tuneable' approach to vision, which could significantly increase patient satisfaction rates and reduce the frequency of corrective follow-up surgeries for presbyopia.
